<unk>  is an hematopoietic that is FDA approved for the treatment of non-Hodgkin's lymphoma and multiple myeloma.   Common adverse reactions include diarrhea, nausea, fatigue, injection site reactions, headache, arthralgia, dizziness, and vomiting.
Plerixafor
Eliglustat
Cromolyn 
Methapyrilene
Dexpanthenol
Miglustat
Tiotropium
Montelukast